Ezekiel saw the wheel.

Knowledge is not the same as wisdom. Freewill is not possible for those that remain mentally enslaved. Human divisions are artificial to allow people to rule.

[Ezekiel saw the wheel. @Ezehtim]

$AKBA highly manipulated stock/company.
Over the last few months crooks have been trying to exit their short positions by intermittently dropping the price then rebound, then drop.
They will let this likely run in anticipation of approaching approval

[Ezekiel saw the wheel. @Ezehtim]

$AKBA FYI, the criminals which also work in hand with many of the trading platforms have information on your stop loss and limit sell orders.
They will use that to their advantage.

[Ezekiel saw the wheel. @Ezehtim]

$AKBA until you see market cap $500 million this remains a buy
Undervalued until $750 million market cap

[Ezekiel saw the wheel. @Ezehtim]

$AKBA based on price action there is long standing efforts to shake off retail

[Ezekiel saw the wheel. @Ezehtim]

$AKBA for all the realities of CEO Butler: He did not give the drug away. Contract has a very narrow indication and an
Excellent tiered renumeration if up to 30%.

[Ezekiel saw the wheel. @Ezehtim]

$AKBA only clown selling and short clowns trying to cover lower
We will be at $2 soon

[Ezekiel saw the wheel. @Ezehtim]

$AKBA this company’s profitability lies in MDS/myelofibrosis and other refractory hematological indications

[Ezekiel saw the wheel. @Ezehtim]

$AKBA market cap should already be over $500 million. With US approval MC should be $1.5 billion.
Buyout should be $2-2.5 billion
Expect additional indications for their drug later this year.

[Ezekiel saw the wheel. @Ezehtim]

$AKBA now they have a partner in Europe without further cash burn by the company.
Critical info is that this is strictly for anemia relate to patients in hemodialysis. The market profitability for other indications will outweigh t... https://t.co/Nl9UQNCCwP

[Ezekiel saw the wheel. @Ezehtim]

$AKBA short covering will occur, and likely still some games
Company is now more attractive than ever.
ARDS is the game changer

[Ezekiel saw the wheel. @Ezehtim]

$AKBA still here.
No reason why PPS should be less than $5 at this moment.
FDA approval was meant to delay this company’s footprint in the market and give the as to big Pharma.
This company has to partner or be bought out in the next 12 months

[Ezekiel saw the wheel. @Ezehtim]

$AKBA $500 million market cap likely very soon

[Ezekiel saw the wheel. @Ezehtim]

$AKBA don’t be faked out. This will very likely reach $500 million cap soon.
Big Pharma and their henchmen/fda are at work. Move up and down then you will see days of 100-200% gains

[Ezekiel saw the wheel. @Ezehtim]

$AKBA big Pharma is corrupt and coordinated with the FDA to suppress these small drug companies

[Ezekiel saw the wheel. @Ezehtim]

$AKBA expecting this to reach $500 million cap soon.
FDA rejected its approval to give big Pharma GSK. A leg up on the US market although GSK data looked worse for thrombosis, ulcers and second malignancy.
Expect US approval with b... https://t.co/hW3l0jQk6q

[Ezekiel saw the wheel. @Ezehtim]

@SouthwestAir please respond to my direct message
Time sensitive

[Ezekiel saw the wheel. @Ezehtim]

$SRRA they bought it cheap!

[Ezekiel saw the wheel. @Ezehtim]

@united please respond to my DM

[Ezekiel saw the wheel. @Ezehtim]

@united please assist with DM

[Ezekiel saw the wheel. @Ezehtim]

@united can you please assist with my DM